Individual differences in pain perception are of key interest in basic and clinical research as altered pain sensitivity is both a characteristic and a risk factor for many pain conditions. It is, however, unclear how individual susceptibility to pain is reflected in the pain-free resting-state brain activity and functional connectivity. Here, we identified and validated a network pattern in the pain-free resting-state functional brain connectome that is predictive of interindividual differences in pain sensitivity. Our predictive network signature (https://spisakt.github.io/RPN-signature) allows assessing the individual susceptibility to pain without applying any painful stimulation, as might be valuable in patients where reliable behavioural pain reports cannot be obtained. Additionally, as a direct, non-invasive readout of the supraspinal neural contribution to pain sensitivity, it may have broad implications for translational research and the development and assessment of analgesic treatment strategies.
Introduction
Pain is a subjective, unpleasant sensory and emotional experience 1 that is highly variable across individuals 2 . Individual differences in pain perception are of key interest in clinical practice as altered pain sensitivity is both a characteristic and risk factor for many pain conditions [2] [3] [4] . In the past decades, brain imaging has revealed the richness and complexity of brain activity underlying both the acute pain experience 5, 6 and pain sensitivity 7, 8 . Still, the central nervous mechanisms determining individual differences in pain perception are poorly understood, partly because past neuroimaging research has mainly focussed on the momentary (acute or chronic) pain experience. The common practice of using pain-free episodes merely as a baseline reference makes studies inherently blind to components of brain activity that are not timelocked to painful events but still central to pain processing and perception. Brain activity in the 'resting-state' (i.e. in absence of any task or stimulation) is known to mirror some, if not all, task-induced activity patterns 9 . For instance, the well-known 'large-scale resting-state networks' 10 (RSNs) strongly resemble patterns of related tasks 11 . Moreover, resting state activity can predict behavioural performance, perceptual decisions and related neural activity 12, 13 . Given the tight link between resting-state and task-induced brain activity, it is highly plausible that activity and functional connectivity during pain-free resting-state conditions reflect the individual's susceptibility to pain. Following the RSN-related terminology, we refer to this type of neural activity as the 'resting-state network of pain susceptibility'. This proposed pain-related resting-state network might have been captured by studies reporting that brain activity and connectivity directly preceding pain [14] [15] [16] [17] [18] [19] [20] [21] and the variability of restingstate fMRI signal 22 in pain-free state is associated with the neural response to nociception and the resultant pain experience. However, due to the small sample sizes, highly varying methodology (e.g. regarding the correction of physiological and motion artefacts) and the lack of validation in these previous studies ('replication crisis' 23 ), the predictive power and clinical relevance of this kind of resting-state brain activity remains unclear to date 24 . Mapping the resting-state network of pain susceptibility and exploiting its capacity to predict various aspects of pain processing would substantially advance the field -both from a basic research and translational perspective. First, contrasting it with experimental pain responses would extend our understanding of how the subjective experience of pain emerges from brain activity. Second, investigating how the hypothesised resting-state pain susceptibility network is embedded into the broader resting-state brain activity could extend our knowledge about the complex functional architecture of the resting brain. Finally, and most importantly, a robust, generalizable and rigorously validated prediction of pain sensitivity -based on the 'resting-state network of pain susceptibility' -could lay the foundations for a non-invasive neuromarker of an individual's sensitivity to pain. Such a resting brain network-based biomarker could be an essential part of a future 'pain biomarker composite signature' 24 required for diagnosis and for evaluation of risk of developing pain and of analgesic efficacy and objectively characterise pain conditions and analgesic treatment effects in experimental and clinical pain research. Here, we investigated the capacity of pain-free resting-state functional brain connectivity to predict individual pain sensitivity in a sample of a total of N=116 young healthy participants. We first performed a whole brain search for specific features of the pain-free resting-state connectome, which are predictive for individual pain sensitivity in a sub-study used only for the 'training' and 'internal validation' of the predictive model. Then, we performed a prospective validation of the approach in terms of predictive performance, generalisation and potential confounders in two independent sub-studies acquired at different scanning sites ('external validation'). Finally, we performed a 'reverse-mapping' of the predictive model to identify the key nodes of the hypothesised network, hereinafter referred to as the 'Signature of the Resting-state Pain-susceptibility Network' (abbreviated as RPN-signature).
Results

Functional connectivity-based prediction and independent multi-centre validation
Resting-state functional MRI data were obtained from a total of N=116 healthy volunteers over three separate sub-studies, performed in three different imaging centres. Neuromarker development was based on intrinsic whole-brain functional brain connectivity, the degree to which resting-state brain activity in distinct neural regions is correlated over time (in the absence of any explicit task). Direct functional connectivity was assessed between M=122 functionally defined regions (Figure 1) . Heat, cold and mechanical pain thresholds obtained according to the well-established quantitative sensory testing (QST) protocol 25 were aggregated in a composite pain-sensitivity score, as previously reported 8 . Whole-brain resting-state functional connectivity data of study 1 (N1=35, after exclusions) was used as the input featurespace (P=7503 features per participant) to predict individual pain sensitivity scores, leading to a typical "large P -small N" setting. According to these conditions, we constructed a machine-learning pipeline, consisting of feature-normalisation, feature-selection and fitting an elastic net regression model. Model training consisted of fitting the pipeline and optimising its hyperparameters in a leave-oneparticipant-out cross-validation framework to improve generalisation to new data. Calculating functional brain connectivity from resting state fMRI measurements. Raw brain images of N=116 participants, in total, underwent automated artefact removal, involving despiking, nuisance regression, bandpass filtering and censoring of motion contaminated time-frames. The effects of these procedures on the BOLD signal are exemplified on the carpet-plots (A, x: time, y: voxel, colour: intensity). Subsequently, a multi-stage, high-precision brain atlas individualisation was performed to obtain regional grey-matter signals for M=122 functionally defined brain regions (B). Partial correlation between all possible region pairs was computed to asses direct functional connectivity and ordered based on large-scale modularity to form individual connectivity matrices. Partial correlations of all regions with the global grey matter signal was retained to account for, but not completely discard the effect of the "global signal", a component of brain activity often regarded as a confound but also related to e.g. vigilance 26 . (C) Subject-level connectivity matrices (depicted by the group-mean connectivity matrix) from Study 1 served as an input for machine-learning-based prediction of behavioural pain sensitivity. The functional connectivity workflow, together with the predictive model, is open-source and shared with the community as a docker container (https://spisakt.github.io/RPN-signature).
In Study 1, QST-based pain sensitivity values ranged from -1.45 to 1.52 with a robust range (range between the 5 th and 95 th percentiles) of 2.57 (in arbitrary units). Internal validation (i.e. performance on left-out participant data) revealed that the model predicts pain sensitivity with a mean absolute error of MAE1=0.56 (mean squared error: MSE1=0.32, median absolute error: MedAE1=0.27, Explained variance Expl.Var.1=39%, Pearson's r1=0.63, p1=0.00006, Figure 2B ). Diagnostics of the model fit (learning curve analysis, Figure 2A ) suggested that the approach reduced overfitting and that sample size was sufficient for an acceptable generalisation. The machine-learning pipeline with the optimal hyperparameters was finally fitted to the data of all participants in Study 1 and saved for further use. The model trained in Study 1 is henceforth referred to as the signature of the Resting-state Pain-sensitivity Network (or short, RPN signature). The full pipeline is deployed as a BIDS-app, a software tool following the Brain Imaging Data Structure (BIDS) specification 27 (https://spisakt.github.io/RPN-signature). As pre-registered on the 7 th of March, 2018 (http://osf.io/buqt7), external validation studies (Studies 2 and 3) were performed in different imaging centres with different MRI scanners (from three different vendors) and with different research staff. The learning-curve (A) suggests that the size of the training sample (Study 1) was sufficient to substantially reduce overfitting and improve generalisation. Internal cross-validated prediction in the training sample (B) and prospective external validation in the test samples (Studies 2 and 3, C) revealed considerable predictive accuracy, robustness, and multi-centre generalisability of the RPN-signature. Mean absolute error (MAE) of the prediction is depicted by dashed lines. While the prediction target was the composite pain sensitivity score, the predicted values correlate with its sub-components, the QST sensory modalities (cold, heat and mechanical pain thresholds, D), as well. Shaded ribbons imply the 95% confidence intervals for the regression estimates. On panel D, points represent the means values of quartile-based sub-groups and bars represent standard errors.
The multi-centre design, together with a reasonable variability in imaging sequences (see Table  2 of the on-line methods) introduced an inherent heterogeneity ensuring that test samples are maximally independent and provide a realistic estimate of prediction accuracy and generalisability. In Studies 2 and 3 (N2=37 and N3=19, after exclusions), QST-based pain sensitivity values ranged from -1.82 to 1.57 and from -1.2 to 0.55, with a robust range of 2.3 and 1.43, respectively (in arbitrary units). External validation ( Figure 2C ) revealed a considerable generalisability of the predictive model: the mean absolute prediction error was MEA2=0.73 and MAE3=0. 42 43 and r3=0.47, p2=0 .008 and p3=0.04). The predicted pain sensitivity score was not only correlated with the observed QST-based composite pain sensitivity score but also with its modality-specific components, the cold, heat and mechanical pain thresholds (CPT, HPT and MPT, respectively) in both Study 2 (rCPT,2=0. 35, rHPT, 2=0.48, rMPT, 2=0.10) and Study 3 (rCPT,3=0.30, rHPT,3=0.07, rMPT,3=0.30) ( Figure 2D ). Summary statistics of pain sensitivity, in-scanner motion and demographic data are reported in Table S1 . Table 1 . Confounder analysis: The RPN signature-response is specific to pain sensitivity. No significant association (p < 0.05) was found with any of the confounder variables. Effect sizes with R 2 ³ 0.09 (medium effect size according to Cohen 28 ) and p-values less than 0.1 is denoted by bold letters. In Study 1, MRI and QST was performed on the same day, otherwise it was measured within 1-5 days. GABA and glutamine/glutamate levels were measured by MR spectroscopy in regions of the pain matrix 8 . Abbreviations: FD: framewise displacement, % scrubbed: number of censored time-frames, BP: blood pressure, mens. day: number of days since the first day of menstruation on the MRI-day, catas.: catastrophising, sensitiv.: sensitivity, CDT, WDT, MDT: cold, warmth and mechanical detection thresholds, T50: temperature inducing moderate pain. BP is reported here as measured on the day of the MRI measurement. See Table S3 for additional covariates (trait anxiety and BP on the day of QST measurement, all p>0.1). 
MRI
Potential confounds and specificity to pain sensitivity
To ensure that the RPN-signature captures the pain-related neural processing in the pain-free resting state, the potential contribution of two types of confounds has to be ruled out: (i) imaging artefacts (e.g. head motion artefacts 26 ) and (ii) demographic or behavioural variables correlated with individual pain sensitivity (e.g. age and sex are known to be slightly correlated with QST thresholds 25 ). Table 1 lists the investigated (pre-registered) confounder variables and their correlations to the predicted pain sensitivity score (together with the corresponding p-value) in all three studies. The pain sensitivity score predicted by the RPN-signature was not significantly associated with any of the confounder variables (p>0.05 for all variables Table  S1 . Network-nodes are color-coded and displayed in 3D-views. Note that, the utilised brain atlas is based on an entirely data-driven functional parcellation and is, therefore, not fully bilateral. Where laterality (L: left, R: right) is not explicitly specified, the atlas did not distinguish the region from its contralateral homolog. (B) Regional predictive strength map of the RPN-signature. Colour-bar depicts 'region-wise predictive strength' (sum of the weights of all connections for the region, multiplied by the study-specific regional probability map). Regions with an absolute predictive strength greater than 0.1 are annotated. Abbreviations: CER: cerebellum, roman numbers: cerebellar lobes, GM grey matter, VAN 
The RPN-signature: the predictive resting-state network of the pain sensitivity
In the applied machine-learning pipeline, non-zero regression coefficients naturally delineate the predictive sub-network. Each coefficient can be interpreted as the relative "importance" of the connectivity in the prediction. Positive (negative) coefficients translate to "stronger interregional functional connectivity predicted higher (lower) sensitivity to pain". The RPN-signature model, trained in Study 1, retained 21 non-zero links out of the total number of 7503 functional connections. The predictive connections are listed in Table 2 and the predictive network is depicted on the chord plot of Figure 3B . Almost half of the variance in the predicted pain sensitivity score is explained by the 4 "strongest" connections. The most important positive predictive connections are found between: (i) the posterior putamen (pPut) and a region including parts of the parietal operculum and the posterior superior temporal gyrus (PO/pSTG); (ii) the frontal poles (FP) and the cerebellar lobule V; and (iii) the right anterior crus II of the cerebellum and the lateral precentral gyrus (lPrCG, primary motor cortex). The only negative predictor among the 'top 4' connections was a connection between the supplementary motor cortex and the posterior part of cerebellar lobule VI. Several other interregional connections and, additionally, the global grey matter signal was also found contribute to the predicted pain sensitivity.
To simplify the overview of the spatial pattern of regions involved in the RPN-signature, we calculated the node-wise sums of predictive weights and multiplied it with the study-specific regional probability-maps. The resulting node-wise predictive strength map is displayed on Figure 3A . To aid the interpretation of our results, we contrasted the localisation of the networknodes in the RPN-signature ( Figure 4C ) to two voxel-level multivariate pain-signatures, the Neurologic Pain Signature (NPS, Figure 4A ) and the "extra-nociceptive", stimulus independent contribution to pain processing, as represented by the Stimulus Intensity Independent Pain Signature-1 29 (SIIPS1, Figure 4B ). There is a striking overlap between the RPN network nodes and voxel-level multivariate painsignatures, involving the aIns, pgACC, PO, pPut, SMC, thalamus (Thal, posterior part, also including the habenula, Hb) and in case of the SIIPS1, also the FP, PrCG, PoCG, PrC, MFG (dlPFC), LOG (vlPFC) and the cerebellar crus II, lobules I-V and vermal regions. Note that the signs of the predictive weights of the NPS and the SIIPS1 represent brain activity and it is, therefore, not directly comparable to the RPN node-wise predictive connectivity weights. Analysing the contribution of the seven large-scale resting-state networks (RSNs from the MIST brain atlas, Figure 4D ) to these patterns revealed that the functional conglomerate consisting of the ventral attention and salience networks, the basal ganglia and the thalamus (VAN+SN+BG+Thal) and, additionally, the CER and the SMN were highly involved in all three patterns. The NPS exhibited the strongest relative VAN+SN+BG+Thal network activation. Moreover, it displayed a stronger MLN and FPN and a lower visual network (VN) and CER contribution than the SIIPS1. The RSN-wise pattern of the RPN-signature was similar to both of the NPS and the SIIPS1, but seems to be closer to the Stimulus Intensity Independent Signature of pain processing. The anterior insula (aIns), thalamus (Thal), parietal operculum (PO), putamen (Put), anterior cingulate (ACC) and supplementary motor (SMC) cortices, where pain-elicited activation is predictive of the intensity of pain, as mapped by the Neurologic Pain Signature (NPS, A) 30 , are also network-nodes in the RPN-signature (C and black outlines on A, B and C).
The overlap with pain-regions is even more striking if the effect of stimulus intensity is ruled out, as in the case of stimulus intensity independent pain signature-1 (SIIPS1, B) 29 . The pain-elicited activity of the lateral orbital gyrus (LOG), left middle frontal gyrus, (MFG), perigenual anterior cingulate cortex (pgACC), precentral gyrus (PrCG), parietal operculum (PO), postcentral gyrus (PoCG) and several cerebellar regions (mostly the crus II and vermis VIII) is predictive to stimulus-intensity independent pain experience and their resting-state functional connectivity predicts individual pain sensitivity. Focusing on the involvement of the large-scale functional brain networks in the investigated predictive patterns (D) reveals that the activity/connectivity of the ventral attention network (VAN), salience network (SN), basal ganglia (BG), thalamus (Thal) and somatomotor network is prominent in all investigated predictive signatures. Moreover, while the NPS involves the mesolimbic network, cerebellar activity/connectivity strongly affects the SIIPS1 and the RPN signatures. Note that, while the spatial patterns of the signatures show a considerable overlap, the voxel-level activity-based signatures (NPS and SIIPS1) are conceptually different from the network-level RPN-signature, therefore a direct comparison of the magnitude and sign of the predictive weights and regional predictive connectivity strengths is not possible.
Discussion
Here we report the RPN-signature, an objective, brain-based measure of pain sensitivity, based on functional connectivity acquired during pain-free resting-state. The applied prospective validation procedure establishes solid foundations for promising basic research and translational applications. The RPN-signature is to be applied together with a fixed resting-state fMRI analysis pipeline (freely available as source-code and Docker-based BIDS-application at https://spisakt.github.io/RPN-signature) and provides the opportunity for out-of-the-box resting-state fMRI-based, non-invasive characterisation of pain sensitivity. This work addresses an important gap in basic research by providing strong evidence for the association of pain-free resting-state functional brain connectivity with neural processing of painful stimuli and the corollary pain experience. The identified functional network pattern provides novel insights into this -commonly unaccounted -component of resting-state brain activity and substantially advances our understanding of the neural mechanisms underlying an individual's pain sensitivity. We used a pre-registered, multicentre design and deployed a substantial sample size to perform a rigorous prospective validation of our predictive model. Therefore, the RPN-signature may serve as an objective neuromarker of interindividual differences and alterations in pain sensitivity [2] [3] [4] .
It is important to distinguish our study of the "pain-free" resting-state from other predictive efforts in pain research, like patient-control classification studies 31 (but also "pain decoding" 30 ), which examine brain activity in experimental or chronic pain conditions, i.e. in the presence of painful experience. Note, that in studies of chronic pain, the terminology "resting-state" usually refers to the lack of explicit experimental pain stimuli in the data acquisition paradigm, but not to the lack of ongoing spontaneous pain experience.
In contrast, the RPN-signature is based on brain activity measured in the absence of any ongoing painful experience (which we refer to as "pain-free" resting-state). Therefore, it introduces a conceptually new modality for future efforts of building a composite pain biomarker 24 .
Predictive power and clinical relevance of the RPN-signature
The RPN-signature predicts a considerable amount of the variance in individual pain sensitivity (39% with internal validation and 18%-19% with external validation, Figure 2 ) which, according to Cohen's recommendations 28 , can be considered as being in the 'medium-to-large' range. The mean absolute error (MAE) of the prediction was 0.73 and 0.42 in the external validation studies (and 0.56 with internal validation). Interpreting the magnitude of the error in comparison to the min-max-range (3.39) and the inter-quartile-range (1.04) of the observed pain sensitivity values strongly suggests that the predictive power of the RPN-signature is clinically relevant in the context of chronic pain 32 and renders the RPN signature deployable in numerous applications. Here, we discuss three aspects of evaluating the relevance of the achieved predictive performance. First, the prediction accuracy we report is similar to those in previous resting state fMRI studies of other target variables (see e.g. Table A2 of Ref. 33 ). However, we would like to point out the majority of previously used fMRI-based predictive models were only internally validated (i.e. the same dataset was used for model training and validation) whereas our validation is based on two independently acquired samples at different scanning sites. The level of prediction accuracy we reached in this more rigorous, prospective approach therefore underscores the robustness of the findings. Second, our study is based on a large sample size (N=116) and the external validation featured heterogeneity regarding methodology, infrastructure, research personnel and a 1-5-day delay between the QST and the MRI measurements (which were at the same day in the training dataset, see Table S1 for further details). Our study thus overcomes recent concerns about common methodological pitfalls of neuroimaging based predictors 34, 35 . While prediction accuracy estimates could likely be higher with a stricter standardisation of the research protocols, the above reported estimates are expected to robustly generalise to a wider variety of resting-state fMRI datasets. Third, we believe that relying solely on the QST-based predictive accuracy might lead to underestimating the utility of the RPN-signature. While Quantitative Sensory Testing is the gold standard approach to assess pain sensitivity, it is a measure of subjective experience, shaped by peripheral, spinal and supraspinal processes convolved with perceptual and behavioural error components 36 
Neuroscientific validity and specificity of the RPN-signature
The predicted pain sensitivity is not only correlated with the observed composite pain sensitivity score but also with its sub-components, the cold, heat and mechanical pain thresholds. The facts that the predicted score shares variance with the sensory modality-specific pain thresholds is remarkable as the predictive model was only informed about the composite score during training. On the other hand, neither the investigated imaging artefacts nor the observed demographic or behavioural variables were significantly correlated with the predicted pain sensitivity values. In sum, our analysis strongly suggests that the predictive power of the RPN-signature is (i) based on signal of neural origin, (ii) is specific to pain sensitivity and (iii) is not driven by the general sensitivity to sensory stimuli or pain-related psychological variables such as anxiety, depression or sleep quality. QST pain thresholds are known to differ between sexes and in different phases of the menstrual cycle. Their moderate (but statistically not significant) correlations with the predicted pain sensitivity score suggest that the RPN-signature partially captures the neural correlates of these effects. The weak (R 2 =0.09, p=0.08) correlation with Glutamate/Glutamine levels in pain processing regions suggest that the RPN-signature also captures the previously reported 8 neurotransmitter-level-dependence of individual pain sensitivity. The pain sensitivity scores, predicted by the RPN-signature seem to be also slightly associated to the delay (days) between the MRI and QST measurements, which suggests that pain sensitivity and its resting-state neural correlates are subject to dynamic changes within the scale of days.
The "Resting-state Pain-sensitivity Network"
The identification of the resting-state connectome that predicts an individual's pain sensitivity yields important conceptual advances in our understanding of the neural mechanisms underlying pain sensitivity and -likely the susceptibility to pain chronification. Many of the key hubs of the RPN-signature, such as the PO/SII, pPut, SI, dlPFC, habenula (Hb), pgACC and aIns (Figure 3 and Figure 4 ) have commonly been associated with pain. The connectivity between the PO/STG area (comprising SII) and pPut displayed the greatest predictive power with a positive association with pain sensitivity. Notably, the PO/STG belongs to the same functional complex as the dorsal posterior insula 37 . The predictive power of this connection corroborates findings suggesting that subregions of the PO 38 and the dpIns 39 are specific to nociception and pain related percepts. The involvement of the pPut in pain-related and affective sensorimotor processes is also well known; particularly it shows pain intensity related and partially somatotopic activation during painful stimulation 40, 41 . Moreover, a recent finding links grey matter density in pPut and pIns to pain sensitivity 41 . According to current concepts, the multifaceted experience of pain results from the integration of nociception and the cognitive-emotional state of the individual 42 . Within such framework, a stronger restingstate co-activation of the pPut and SII (and dpIns) might imply that the sensory aspects of salient (and possibly nociceptive) inputs have an elevated 'weight' in this integrative process. The integration of cognitive-emotional states into pain perception might be reflected by the activity and connectivity of the dlPFC. Indeed, we found that the connectivity between the postcentral gyrus (SI) and the dlPFC is positively associated with pain sensitivity. This is very much in line with a recent finding 43 , showing that neuromodulation of the dlPFC introduces decreased pain-related activity in sensory-motor areas (and increased activity in the pIns and thalamus) and that this change in activation, together with the resulting analgesic effect, is linked to structural connectivity between the dlPFC and the thalamus. Modulatory function of both the dlPFC and the caudate-putamen might be projected to the brainstem and particularly to the antinociceptive periaqueductal grey (PAG, not investigated in the present study) by the habenula 44 , which we also found to contribute to the predicted pain sensitivity score. The relevance of this pathway in shaping one's sensitivity to pain is supported by the previously observed negative correlation between resting-state mPFC-PAG connectivity and intrinsic attention to pain 45 .
In addition to connectivity within the 'sensory-frontal-striatal-habenula' complex which explains about 25% of the predicted pain sensitivity score, a second 'cluster' of connections also contributes to pain sensitivity. At the centre of this cluster is the cerebellum and its connections to frontal and sensory-motor regions (frontal pole, dlPFC, PrCG, PoCG, SMC). Our finding that the cerebellum significantly shapes individual pain sensitivity corroborates previous reports (see e.g. Ref. 46 -study on patients with cerebellar infarcts and pain sensitivity and pain modulation by placebo) and highlights the cerebellum as a promising novel target for related research. Another component of the RPN are the perigenual anterior cingulate cortex (pgACC), known for its integrative and modulatory role in pain processing and related decision-making 47 , and the ventral anterior insula, a region functionally connected to the pgACC and involved in emotion and disgust processing, besides its role in the processing of cognitive-affective aspects of pain 37 . Several connections, exerting small-to-moderate influence on the prediction, involve the occipital lobe. Some of these predictive connections could be interpreted as secondary to pain perception (analogously to the well-known deactivations of visual areas during noxious stimulation) or, alternatively, might be related to the somewhat underreported effect of visual context on pain experience 48 .
From resting-state activity to pain response
While only a few papers have previously highlighted the relationship between resting-state activity and acute pain 22, 45, 49 , several studies have focussed on pain anticipation 12,15-17 i.e. on a pain-free state directly preceding a painful stimulus. In summary, results from these studies suggest that the functional state and connectivity profile of the anterior insula, periaqueductal grey, anterior cingulum, cerebellum and areas of the fronto-parietal network appear to reflect the individuals' momentary susceptibility to potentially painful stimuli. However, from these studies it is unclear to what degree pain sensitivity is modulated by trait-like (anxiety, pain catastrophising) or by state-like (preceding emotional appraisal, attentional or pain-specific mental states) characteristics 50 . In contrast to the short periods used in anticipatory studies, our study is based on a ten-minute-long resting-state period and predicts pain sensitivity measured several days later. Thus, our results strongly support the presence of a trait-like neural signature of pain sensitivity. However, the confounder analysis (association with time between measurements and menstrual cycle) also provides evidence for temporal dynamics.
Limitations
While the validation and testing of the proposed predictive signature is highly reliable in terms of generalizability, here we note that the applied brain atlas, while providing full-brain coverage and a generalizable functional parcellation, still introduces a-priori constrains in laterality and precise localisation of brain regions (e.g. it does not contain the PAG and other brain-stem areas).
Outlook and implication
The identified predictive network signature has important implications from a basic research and clinical perspective and paves the way for future translational research. Investigating how the "resting-state pain susceptibility network" is embedded into the general resting-state brain activity could extend our knowledge about the complex functional architecture of the resting brain and foster our understanding of the mechanisms by which the subjective experience of pain emerges from neural function. Moreover, the RPN-signature allows the better characterisation of various clinical populations (e.g. in post-operative or chronic pain), especially when reliable behavioural pain reports cannot be obtained. The RPN-signature may extend our possibilities to non-invasively characterise clinical populations (e.g. in post-operative or chronic pain), especially when reliable behavioural pain reports cannot be obtained. Our pre-registered, multicentre design covers heterogeneity originating from differences in research setting and ensures the reliability, robustness and generalizability of results necessary for this translation. A future, iterative, bootstrapping-like research process involving a stricter standardisation of experimental procedures and involving clinical populations promises to further improve the predictive capabilities of the RPNsignature.
In sum, the RPN-signature identified here has the potential to become a novel, non-invasive neuromarker for the supraspinal neural contribution to pain sensitivity and the susceptibility to clinical pain states, especially in translational research and development of analgesic treatment strategies, where uncoupling peripheral and central mechanisms is often of crucial interest. Moreover, the RPN-signature might serve as a novel, resting network-based building block in a future 'pain biomarker composite signature' 24 .
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Methods
Study design considerations
The study design was established with careful consideration of recent recommendations, requirements and standards for neuroimaging biomarkers [1] [2] [3] [4] [5] (neuromarkers) and motivated by the following thoughts.
Maximise predictive performance
We employed a standardized pre-processing pipeline to ensure optimal sensitivity of the neuromarker, as sufficient effect size is a basic requirement of any clinical utility 3 . We used high precision image alignment, incorporating individual anatomy when extracting fMRI timeseries data. Moreover, we adopted recent recommendations 6, 7 and protocols 8 regarding artefact reduction and optimised our workflow to meet the special needs of connectome-based analysis. We used our in-house developed, open-source python software library "Pipelines Utilising a Modular Inventory" (PUMI, https://github.com/spisakt/PUMI), which is based on nipype 9 , a community-based Python project providing a uniform interface to existing neuroimaging software and, in part, re-used code from the C-PAC 10 and the niworkflows 11 open-source projects. A predictive modelling ("machine learning") approach was utilised to exploit the rich data provided by resting-state functional brain networks and, potentially, take advantage of 'fMRI hyperacuity' 12 .
Assessing predictive power under realistic conditions
Prospective validity and generalisability to new datasets is an essential property of any neuromarker candidates 3 . Internal validation techniques, often used in related research may introduce various biases when assessing predictive performance [13] [14] [15] . We therefore used a preregistered, external validation strategy, that strictly separated model training and performance assessment. For model training, we exclusively used data from Study 1. We conducted two independent sub-studies (Studies 2 and 3) in different research centres, with different equipment and different research staff for validation. We used a "liberal" alignment of research settings, allowing for a reasonable heterogeneity in procedures, equipment, imaging sequences, language of participant-researcher communication across study-centres, introducing a reasonable heterogeneity in the validation procedure to ensure generalizability.
Ensure that prediction is driven by neural signal and is specific to pain sensitivity. Powerful predictions can be driven by a "third variable", related but different from the measure in question, e.g. systematic movement artefacts. Therefore, assessing the neuroscientific validity of the predictive model is an important step in neuromarker development 3 . To ensure that the proposed marker of pain sensitivity is indeed driven by neural signals associated with pain sensitivity, we evaluated the correlation of the predicted score with various pre-defined (and pre-registered) confounder and validator variables.
Ensure accessibility of results
Biomarker development is a complex, multi-stage process which can be largely facilitated by transparency, accessibility and deployability of the methodology 3 . Therefore, we applied a comprehensive pre-registration and made the source code of the method open-source and freely available for the community (https://spisakt.github.io/RPN-signature). Moreover, we provide a platform-independent, easy to use docker container which provides the opportunity to use our predictive model as a "research product" 3 , to obtain out-of-the box pain sensitivity predictions form any appropriate imaging datasets.
Participants
A total of N=116 healthy, young volunteers were involved in three sub-studies. Age and sex of the participants is reported in Supplementary Table S1 . Study 1 involved N1=39 participants (the same sample as in Ref. 16 ). It was performed at the Ruhr University Bochum (Germany) by MZ and TSW and used as the training sample for the machine learning-based prediction of pain sensitivity and additionally, served as a basis for the internal validation of the prediction. Studies 2 and 3 (N2=48, N3=29) were performed at the University Hospital Essen (Germany) by FS and TS and at the University of Szeged (Hungary) by BK and TK, respectively, and served as samples for external validation. Inclusion criteria and exclusion criteria were largely identical in all three centres and are listed in Methods Table 1 . Recruitment and reimbursement policies varied across centres; participants received 20 €/h in Studies 1 and 2 and no reimbursement in Study 3. Metal implant, unremovable piercing, peacemaker, tattoo in head/neck position, pregnancy or known claustrophobia were considered as contraindication for MR measurement. Participants were required to abstain from consuming caffeine two hours before experiments (except in Study 3) and from consuming alcohol on the day of testing and the previous day.
The study was conducted in accordance with the Declaration of Helsinki and approved by the local or national ethics committees (Register Numbers: 4974-14, 18-8020-BO and 057617/2015/OTIG at the Ruhr University Bochum, University Hospital Essen and ETT TUKEB Hungary, respectively.) All participants gave written informed consent before testing. Imaging and quantitative sensory testing (QST) were performed on the same day in Study 1 and in average 2-3 days apart in Studies 2 and 3 (see Supplementary Table S1 for details). MRI measurement always preceded the QST session.
Methods Table 1 . Inclusion and exclusion criteria during the recruitment process. 
Inclusion criteria Exclusion criteria
Measures -functional MRI
High-resolution anatomical and open-eyed resting-state fMRI measurements were acquired from all participants. Scanning parameters (including equipment) varied across centres and are listed in Methods Table 2 . During measurements, participants were instructed to lie still and relaxed, without falling asleep, and avoid any movement.
Foam padding, and in Studies 1 and 2, pneumatic pillows were used to restrict head movements. All anatomical MRI measurements were screened for incidental findings.
Measures -QST
Heat (HPT), cold (CPT), and mechanical (MPT) pain thresholds were acquired according to the QST protocol 17 . Warmth (WDT), cold (CDT) and in Study 2 and Study 3, mechanical (MDT) detection thresholds were obtained as additional control measures. All sensory measurements were obtained from the palmar left forearm, proximal to the wrist crest. Within the QST framework, thermal thresholds are determined using a method of limits 18 . To this end, increasing and decreasing temperatures were applied to the skin with an MSA thermal stimulator (Somedic, Hörby, Sweden) in Study 1 and Pathway thermal stimulators (Medoc Ltd., Ramat Yishai, Israel) in Studies 2 and 3. In all studies, ATS thermodes were used on a skin surface of 30x30mm, with a baseline temperature of 32°C. Participants were instructed to indicate the onset of pain by button press. For all thermal thresholds 6, rather than 3 (as in the original protocol) 17 , stimulus repetitions were performed to reduce between-subject variance. Furthermore, the first measurement was discarded from analysis as a test stimulus. HPT and CPT were calculated as the arithmetic means of the five remaining threshold temperatures. MPTs and MDTs were determined using a staircase method 18 . Five increasing and five decreasing trains of pinprick (MRC Systems, Heidelberg, Germany) stimuli were applied to the palmar left forearm in an alternating fashion, whereas the participant was instructed to categorize the stimuli as noxious, or non-noxious. Mechanical detection threshold was assessed analogously with von Frey filament stimulations. MPT and MDT were computed as the logtransformed geometric mean force determined in five ascending and descending staircasethresholding-runs.
Additional measures
Age, sex, self-reported height, weight and, for female participants, the date of the first day of the last menses and the use of contraceptives, was recorded prior to all measurements. Additionally, self-reported weekly alcohol consumption and level of education (primary school, secondary school, university) was recorder for Studies 1 and 2. Before the QST, participants filled out the Pain Sensitivity Questionnaire (PSQ) 19 , the Pain Catastrophizing Scale (PCS) 20 , the State-Trait Anxiety Inventory (STAI) 21, 22 , the short German version of the Depression Scale (ADS-K, Center for Epidemiologic Studies) 23 and, additionally in Studies 2 and 3, the Pittsburgh Sleep Quality Index (PSQI) 24 and the perceived stress questionnaire (PSQ20) 25 . In Studies 2 and 3, blood pressure was measured both before the MRI and the QST measurements. Moreover, for Sample 1, T50 values were available from a parallel experiment performed on the day before fMRI testing. T50 represents the temperature (in °C) necessary to induce a heat-pain rating of 50 (on a scale ranging from 0, no pain to 100 unbearable pain). T50 values were obtained from a non-linear (2 nd -order polynomial) interpolation of ratings obtained in response to 15 tonic heat pain stimuli (duration: 16 seconds) between 42,5°C and 48°C, presented in pseudo-randomized "grid search" fashion.
Calculation of Pain Sensitivity
The target variable for the prediction was a single composite measure of individual pain sensitivity summarizing HPT, CPT, and MPT as defined in Ref. 16 .
In Study 1, HPT, CPT, and MPT were Z-transformed (mean centred and standardized) and HPT, as well as MPT were inverted (multiplied by -1), so that higher Z-values denoted higher pain sensitivity. Then, the arithmetic mean of the Z-transformed variables was computed for each participant and defined as "pain-sensitivity score". In Studies 2 and 3, the same procedure was applied, except that Z-transformation was based on the population-mean and standard deviation of Study 1, to ensure that the same scale was used across studies. Extreme QST values were defined using the normative 95% percentiles reported in Ref. 17 ; participants showing extreme HPT, CPT or MPT values in at least two of the three modalities were excluded. This screening resulted in excluding 0, 3 and 2 participants in Samples 1, 2 and 3, respectively (Table S2) .
fMRI preprocessing
As fMRI-based functional connectivity is susceptible to in-scanner motion artefacts [6] [7] [8] 26, 27 , appropriate preprocessing and signal cleaning is key to successful connectivity-based prediction. Resting-state functional MRI data was preprocessed identically in all three studies. The applied, nipype-based workflow is depicted on Figure S1 . It utilised third-party neuroimaging software, code adapted from the software tools C-PAC 10 and niworkflows 11 , and in-house python routines. Brain extraction from both the anatomical and the structural images, as well, as tissuesegmentation from the anatomical images was performed with FSL bet and fast 28 . Anatomical images were linearly and non-linearly co-registered to the 1mm-resolution MNI152 standard brain template brain with ANTs 29 (see https://gist.github.com/spisakt/0caa7ec4bc18d3ed736d3a4e49da7415 for source code). Functional images were co-registered to the anatomical images with the boundary-based registration technique of FSL flirt 28 . All resulting transformations were saved for further use. The preprocessing of functional images happened in the native image space, without resampling. Realignment-based motion correction was performed with FSL mcflirt 28 . The resulting six head motion estimates (3 rotations, 3 translations), their squared versions, their derivates and the squared derivates (known as the Friston-24-expansion 30 ) was calculated and saved for nuisance correction. Additionally, head motion was summarised as frame-wise displacement (FD) timeseries, according to Power's method 26 , to be used in data censoring and exclusion. After motion-correction, outliers (e.g. motion spikes) in time series data were attenuated using AFNI despike 31 . The union of the eroded white-matter maps and ventricle masks were transformed to the native functional space and used for extracting noise-signal for anatomical CompCor correction 32 .
In a nuisance regression step, 6 CompCor parameters (the 6 first principal components of the noise-region timeseries), the Friston-24 motion parameters and the linear trend were removed from the timeseries data with a general linear model. On the residual data, temporal bandpass filtering was performed with AFNI's 3DBandpass to retain the 0.008-0.08Hz frequency band. The prior use of AFNI's despike is expected to attenuate aliasing of residual motion artefacts into the neighbouring time-frames during bandpass filtering [33] [34] [35] . To further attenuate the impact of motion artefacts, potentially motion-contaminated time-frames, defined by a conservative FD>0.15mm threshold, were dropped from the data (known as "scrubbing" the data) 33 . Participants were excluded from further analysis if the mean FD exceeded 0.15mm, or when more then 30% of frames were "scrubbed". This resulted in exclusion of 4, 8 and 7 participants in Samples 1, 2 and 3, respectively (Table S2 ). Quality-control (registration-check, carpet-plots, see e.g. Figures S2-4 ) was performed throughout the workflow.
Functional connectivity analysis
The 122-parcel version of the MIST 36 multi-resolution functional brain atlas and grey matter masks obtained from the anatomical image were transformed to the native functional space. Native-space atlas regions were then masked with the grey matter masks that were obtained from the anatomical image and transformed to functional space previously. Voxel-timeseries were averaged over these individualised MIST regions and, together with the mean grey matter signal, retained for graph-based connectivity analysis. Regional timeseries were ordered into large-scale functional modules (defined by the 7-parcel MIST atlas) for visualization purposes (Figure 1 ). Partial correlation was computed across all pairs of regions (and global grey matter), as implemented in the nilearn 37,38 python module. Partial, rather than simple correlations were used to rule out indirect connectivity 39 . Our graphmodelling approach ensured that the global-grey matter signal is handled as a confound during computing the partial correlation coefficients but, at the same time, also considered it as a signal of interest, as it may represent vigilance related processes 40 . Partial correlation coefficients were organised to 123 by 123 (122 regions + global grey matter signal) symmetric connectivity matrices. The upper triangle of these matrices was used as the feature space for machine learning-based predictive modelling.
Predictive model training and validation
Whole-brain resting-state functional connectivity data of study 1 (N1=35, after all exclusions 16 , Supplementary Table S2 ) was used as the input feature-space (P=7503 features per participant) to predict individual pain sensitivity scores, leading to a "large P -small N" setting.
We constructed a machine learning pipeline (https://github.com/spisakt/RPNsignature/blob/master/PAINTeR/model.py) in scikit-learn 37, 41 , consisting of robust feature scaling (removes the median and scales with data quantiles), pre-selection of features 42 , selecting the K "best" features with strongest relationships to the target variable and an Elastic Net regression model 43 Hyperparameter optimisation was performed in a leave-one-participant-out cross validation (internal validation phase). Crossvalidation incorporated the complete machine-learning pipeline to avoid introducing dependencies between the training and test samples. Note that fMRI preprocessing was independent between subjects, thus not included in the cross-validation. Optimal hyperparameters were found to be K=25, L1/L2-ratio=0.999 and alpha=0.005. External validation was performed by applying the RPN-signature on the fMRI data of Studies 2 and 3 (N2=37, N3=19, after exclusions, Supplementary Table S2 ). The resulting predictions were compared with the observed QST-based pain sensitivity scores by calculating mean squared error and explained variance. In addition, we fitted a linear model to predicted and observed pain sensitivity scores, obtaining p-values for the relationship.
Confounder analysis
To explore potential confounding variables, the predicted pain sensitivity-scores (or crossvalidated predictions in case of Sample 1) were contrasted to mean and median FD, the percentage of scrubbed volumes, systolic and diastolic blood pressure before both the MRI and QST measurement (as blood pressure was earlier reported 44 to be associated with sensitivity to mechanical pain), the time delay between MRI and QST testing (to test for temporal stability of the prediction), age, sex, BMI, number of days since the first day of the last menses, alcohol consumption (units/week), level of education, state and trait anxiety (STAI), score of depressive symptoms (ADS-K), self-reported pain sensitivity (PSQ) and pain catastrophising (PCS), perceived stress (PSQ20), quality of sleep (PSQI), and non-noxious QST detection thresholds (CDT, WDT and MDT, where available). Moreover, in Study 1 predictions were compared to T50-values and MR spectroscopy-based GABA and Glutamate/Glutamine levels in painprocessing brain regions (see Ref. 16 for details). Associations were tested with linear models.
Visualization of the predictive network
The predictive interregional connections highlighted by the non-zero regression coefficients of the RPN-signature were displayed as a ribbon plot using the R-package circlize 45 (Figure 3 ). Corresponding individualised brain region masks were transformed back to standard space to create a study-specific regional probability map (reflecting co-registration accuracy and individual variability in morphology). Probability maps were multiplied by the sum of corresponding regression coefficients to create a "regional predictive strength" map, which was then visualised with FSLeyes 28 and MRIcroGL (https://www.mccauslandcenter.sc.edu/mricrogl) ( Figure 3 ). Overlap of the regional predictive strength map with two other pain-related maps was also visualized with FSLeyes and MRIcroGL (Figure 4 ). The analysis of large-scale resting-state network-involvement (as defined by the MIST 36 brain atlas) was performed by summarising and Z-transforming the voxel values across the seven regions-of-interest. Polar plot was made with the R-package ggplot2 46 .
Data and software availability
Processed data (regional timeseries) and source code are deposited at https://github.com/spisakt/RPN-signature. Raw imaging data is available at openneuro.org. The RPN-signature scores can be computed based on structural and resting-state functional datasets by the software tool with the same name. The RPN-signature software tool consists of the described MRI processing pipeline and the functional connectome-based predictive model. It is available as source code at https://github.com/spisakt/RPN-signature. As the software follows the Brain Imaging Data Structure (BIDS) 47 and the BIDS-App specification, it provides a standard command line interface and relies on Docker-technology. The docker image is deposited on Docker Hub: (https://cloud.docker.com/repository/docker/tspisak/rpn-signature) and does not depend on any software outside the container image. This, together with the fully transparent continuous integration-based development and automated tagging and versioning, enhances software availability and supports reproducibility of RPN-signature results. 
